Abstract
Determining similarities and differences in brain structure across psychiatric disorders is important to determine if psychiatric taxonomy is reflected in distinct brain structural changes. As previous neuroimaging meta-analyses have typically focused on a single disorder, precluding transdiagnostic comparisons, we aimed to quantify patterns of similarity and differences between psychiatric disorders in terms of regional brain volumes. Here we show, in network and pairwise meta-analyses of 498 studies (51,227 individuals, 17 psychiatric disorders and 17 brain regions), that psychiatric disorders show both distinct and overlapping patterns of brain volume gain and loss. A principal components analysis demonstrated that the first principal component could account for 48% of variance and corresponded to a pattern of increased basal ganglia and decreased hippocampal and amygdala volumes. This component loaded most strongly for disorders on the psychosis spectrum, and most weakly for affective disorders. Our findings illustrated that, while similar volumetric alterations are frequently shared between disorders, neuroanatomical patterns also appear related to clinically meaningful categories. (PROSPERO Registration: CRD42020221143.)
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$79.00 per year
only $6.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data were obtained from publicly available research accessed via MEDLINE, EMBASE and PSYCHINFO databases.
Code availability
All code is available at https://github.com/rob-mccutcheon/volumetric_network_meta.
Change history
26 May 2023
In the version of this article initially published, the name of Toni-Ann Heron appeared as Toni Ann-Heron; the error has been corrected in the HTML and PDF versions of the article.
References
Goodkind, M. et al. Identification of a common neurobiological substrate for mental Illness. JAMA Psychiatry 72, 305–315 (2015).
Rogdaki, M. et al. Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis. Mol. Psychiatry 25, 1704–1717 (2020).
Brugger, S. P. & Howes, O. D. Heterogeneity and homogeneity of regional brain structure in schizophrenia. JAMA Psychiatry 74, 1104 (2017).
Opel, N. et al. Cross-disorder analysis of brain structural abnormalities in six major psychiatric disorders: a secondary analysis of mega- and meta-analytical findings from the ENIGMA consortium. Biol. Psychiatry 88, 678–686 (2020).
Wise, T. et al. Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis. Mol. Psychiatry 22, 1455–1463 (2017).
Radonjić, N. V. et al. Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders. Mol. Psychiatry 26, 2101–2110 (2021).
Eickhoff, S. B., Bzdok, D., Laird, A. R., Kurth, F. & Fox, P. T. Activation likelihood estimation meta-analysis revisited. NeuroImage 59, 2349–2361 (2012).
Efthimiou, O. et al. GetReal in network meta-analysis: a review of the methodology. Res. Synth. Methods 7, 236–263 (2016).
McCutcheon, R. et al. Magnitude and variability of structural brain abnormalities in neuropsychiatric disease: protocol for a network meta-analysis of MRI studies. Evid. Based. Ment. Health 24, 111–114 (2021).
Vernon, A. C. et al. Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol. Psychiatry 71, 855–863 (2012).
Huhtaniska, S. et al. Long-term antipsychotic use and brain changes in schizophrenia—a systematic review and meta-analysis. Hum. Psychopharmacol. 32, e2574 (2017).
Jauhar, S. et al. A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry 74, 1206–1213 (2017).
Barnow, S. et al. Borderline personality disorder and psychosis: a review. Curr. Psychiatry Rep. 12, 186–195 (2010).
Anttila, V. et al. Analysis of shared heritability in common disorders of the brain. Science 360, eaap8757 (2018).
Crivellato, E. & Ribatti, D. Soul, mind, brain: Greek philosophy and the birth of neuroscience. Brain Res. Bull. 71, 327–336 (2007).
Cheon, E. J. et al. Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: a review of ENIGMA findings. Psychiatry Clin. Neurosci. https://doi.org/10.1111/pcn.13337 (2022).
Patel, Y. et al. Virtual histology of cortical thickness and shared neurobiology in 6 psychiatric disorders. JAMA Psychiatry 78, 47–63 (2021).
Bromis, K., Calem, M., Reinders, A. A. T. S., Williams, S. C. R. & Kempton, M. J. Meta-analysis of 89 structural MRI studies in posttraumatic stress disorder and comparison with major depressive disorder. Am. J. Psychiatry 175, 989–998 (2018).
Caspi, A., Houts, R. M., Belsky, D. W. & Goldman-mellor, S. J. The p factor: one general psychopathology factor in the structure of psychiatric disorders?. Clin. Psychol. Sci. 2, 119–137 (2015).
Kotov, R. et al. The hierarchical taxonomy of psychopathology (HiTOP): a dimensional alternative to traditional nosologies. J. Abnorm. Psychol. 126, 454–477 (2017).
Steel, Z. et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int. J. Epidemiol. 43, 476–493 (2014).
Brugger, S. P. & Howes, O. D. Heterogeneity and homogeneity of regional brain structure in schizophrenia: a meta-analysis. JAMA Psychiatry 74, 1104–1111 (2017).
Clementz, B. A. et al. Identification of distinct psychosis biotypes using brain-based biomarkers. Am. J. Psychiatry 173, 373–384 (2016).
Pfefferbaum, A. et al. Variation in longitudinal trajectories of regional brain volumes of healthy men and women (ages 10 to 85 years) measured with atlas-based parcellation of MRI. NeuroImage 65, 176–193 (2013).
Veroniki, A. A. et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res. Synth. Methods 7, 55–79 (2016).
Viechtbauer, W. Confidence intervals for the amount of heterogeneity in meta-analysis. Stat. Med. 26, 37–52 (2007).
Higgins, J. P. T. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002).
Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 315, 629–634 (1997).
Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36, 1–48 (2010).
Rücker, G., Schwarzer, G., Krahn, U. & König, J. netmeta: network meta-analysis using frequentist methods. https://cran.r-project.org/web/packages/netmeta/netmeta.pdf (2015).
Higgins, J. P. T. et al. Consistency and inconsistency in network meta‐analysis: concepts and models for multi‐arm studies. Res. Synth. Methods 3, 98–110 (2012).
König, J., Krahn, U. & Binder, H. Visualizing the flow of evidence in network meta-analysis and characterizing mixed treatment comparisons. Stat. Med. 32, 5414–5429 (2013).
Wells, G. A. et al. Quality assessment form for cohort studies. Ottawa Hospital Research Institute 2–4 (2014). https://www.ncbi.nlm.nih.gov/books/NBK115843/bin/appe-fm3.pdf
Nikolakopoulou, A. et al. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 17, 1–19 (2020).
Stacklies, W., Redestig, H., Scholz, M., Walther, D. & Selbig, J. pcaMethods—a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23, 1164–1167 (2007).
Mowinckel, A. M. & Vidal-Piñeiro, D. Visualization of brain statistics with R packages ggseg and ggseg3d. Adv. Methods Pract. Psychol. Sci. 3, 466–483 (2020).
Acknowledgements
R.A.M. was funded by and NIHR academic clinical lectureship and a Wellcome Trust Clinical Research Career Development Fellowship (224625/Z/21/Z). T.P. is funded by the NIHR. O.D.H. is funded by Medical Research Council-UK (no. MC-A656-5QD30), Maudsley Charity (no. 666), Brain and Behavior Research Foundation, and Wellcome Trust (no. 094849/Z/10/Z) grants and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, and by NIHR. O.E. is supported by Ambizione grant no. 180083 from the Swiss National Science Foundation (SNSF). A.C. is supported by the National Institute for Health Research (NIHR) Oxford Cognitive Health Clinical Research Facility, by an NIHR Research Professorship (grant RP-2017-08-ST2-006), by the NIHR Oxford and Thames Valley Applied Research Collaboration and by the NIHR Oxford Health Biomedical Research Centre (grant BRC-1215-20005). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR or the UK Department of Health.
Author information
Authors and Affiliations
Contributions
R.A.M. and T.P. participated in the conception, drafting, revising and final approval of this manuscript. G.W., L.V., C.C., X.G., T.A.-H., M.G., O.E., A.C., M.R., S.B., D.D. and O.D.H. participated in the revising and final approval of this manuscript.
Corresponding author
Ethics declarations
Competing interests
R.A.M. has received honoraria from Otsuka and Janssen for educational talks. A.C. has received research and consultancy fees from INCiPiT (Italian Network for Paediatric Trials) and CARIPLO Foundation and Angelini Pharma, outside the submitted work. T.P. has participated in speaker meetings organized by Sunovion, Lundbeck, Janssen and Otsuka. O.D.H. is a part-time employee of H. Lundbeck A/S and has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, In-vicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Rand, Recordati, Roche and Viatris/Mylan. The remaining authors declare no competing interests.
Peer review
Peer review information
Nature Mental Health thanks the anonymous reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary methods, figures and tables.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
McCutcheon, R.A., Pillinger, T., Guo, X. et al. Shared and separate patterns in brain morphometry across transdiagnostic dimensions. Nat. Mental Health 1, 55–65 (2023). https://doi.org/10.1038/s44220-022-00010-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44220-022-00010-y
This article is cited by
-
Psychosis superspectrum II: neurobiology, treatment, and implications
Molecular Psychiatry (2024)